RACK1, a clue to the diagnosis of cutaneous melanomas in horses

BMC Veterinary Research

Volumn 8, Issue , 2012, Pages

  Campagne, Cécile ^a,b   Julé, Sophia ^a,b,e   Bernex, Florence ^a,b   Estrada, Mercedes ^c   Aubin Houzelstein, Geneviève ^a,b,d   Panthier, Jean Jacques ^a,b,d   Egidy, Giorgia ^a,b,d  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^b UNIVERSITÉ PARIS EST   (France)

^c Laboratoire IDEXX Alfort   (France)

^d CNRS   (France)

^e CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Diagnosis; Melanoma; MITF; PAX3; RACK1

Indexed keywords

EQUIDAE;

PEPTIDE; PEPTIDE I; TUMOR MARKER;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HORSE; HORSE DISEASE; MALE; MELANOMA; METABOLISM; SKIN TUMOR;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HORSE DISEASES; HORSES; MALE; MELANOMA; PEPTIDES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84862982974     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-8-95     Document Type: Article

References (33)

1. MacGillivray KC, Sweeney RW, Del Piero F. Metastatic melanoma in horses. J Vet Intern Med 2002, 16:452-456. 10.1111/j.1939-1676.2002.tb01264.x, 12141308.
2. Smith SH, Goldschmidt MH, McManus PM. A comparative review of melanocytic neoplasms. Vet Pathol 2002, 39:651-678. 10.1354/vp.39-6-651, 12450197.
3. Broekaert SM, Roy R, Okamoto I, van den Oord J, Bauer J, Garbe C, Barnhill RL, Busam KJ, Cochran AJ, Cook MG, et al. Genetic and morphologic features for melanoma classification. Pigment Cell Melanoma Res 2010, 23:763-770. 10.1111/j.1755-148X.2010.00778.x, 3107973, 20874733.
4. Viros A, Fridlyand J, Bauer J, Lasithiotakis K, Garbe C, Pinkel D, Bastian BC. Improving melanoma classification by integrating genetic and morphologic features. PLoS Med 2008, 5:e120. 10.1371/journal.pmed.0050120, 2408611, 18532874.
5. Andersson LS, Axelsson J, Dubielzig RR, Lindgren G, Ekesten B. Multiple congenital ocular anomalies in Icelandic horses. BMC Vet Res 2011, 7:21. 10.1186/1746-6148-7-21, 3125316, 21615885.
6. Bellone RR. Pleiotropic effects of pigmentation genes in horses. Anim Genet 2010, 41(Suppl 2):100-110.
7. Rosengren Pielberg G, Golovko A, Sundstrom E, Curik I, Lennartsson J, Seltenhammer MH, Druml T, Binns M, Fitzsimmons C, Lindgren G, et al. A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse. Nat Genet 2008, 40:1004-1009. 10.1038/ng.185, 18641652.
8. Egidy G, Jule S, Bosse P, Bernex F, Geffrotin C, Vincent-Naulleau S, Horak V, Sastre-Garau X, Panthier JJ. Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferation. Mol Cancer 2008, 7:34. 10.1186/1476-4598-7-34, 2387171, 18442364.
9. Ron D, Chen CH, Caldwell J, Jamieson L, Orr E, Mochly-Rosen D. Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. Proc Natl Acad Sci U S A 1994, 91:839-843. 10.1073/pnas.91.3.839, 521407, 8302854.
10. Adams DR, Ron D, Kiely PA. RACK1, A multifaceted scaffolding protein: Structure and function. Cell communication and signaling : CCS 2011, 9:22.
11. Berns H, Humar R, Hengerer B, Kiefer FN, Battegay EJ. RACK1 is up-regulated in angiogenesis and human carcinomas. FASEB J 2000, 14:2549-2558. 10.1096/fj.99-1038com, 11099474.
12. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013, 21376230.
13. Zhang J, Zhu F, Li X, Dong Z, Xu Y, Peng C, Li S, Cho YY, Yao K, Zykova TA, Bode AM. Rack1 protects N-terminal phosphorylated c-Jun from Fbw7-mediated degradation. Oncogene 2011, 31:1835-44.
14. Zhang W, Cheng GZ, Gong J, Hermanto U, Zong CS, Chan J, Cheng JQ, Wang LH. RACK1 and CIS mediate the degradation of BimEL in cancer cells. J Biol Chem 2008, 283:16416-16426. 10.1074/jbc.M802360200, 2423247, 18420585.
15. Lopez-Bergami P, Habelhah H, Bhoumik A, Zhang W, Wang LH, Ronai Z. RACK1 mediates activation of JNK by protein kinase C [corrected]. Mol Cell 2005, 19:309-320. 10.1016/j.molcel.2005.06.025, 2953422, 16061178.
16. Fleury C, Berard F, Leblond A, Faure C, Ganem N, Thomas L. The study of cutaneous melanomas in Camargue-type gray-skinned horses (2): epidemiological survey. Pigment Cell Res 2000, 13:47-51. 10.1034/j.1600-0749.2000.130109.x, 10761996.
17. Seltenhammer MH, Simhofer H, Scherzer S, Zechner R, Curik I, Solkner J, Brandt SM, Jansen B, Pehamberger H, Eisenmenger E. Equine melanoma in a population of 296 grey Lipizzaner horses. Equine Vet J 2003, 35:153-157.
18. Schwartz D. Les petits échantillons. Méthodes statistiques à l'usage des médecins et des biologistes 1996, 151-162. Paris, Flammarion M-S, 4.
19. He S, Yoon HS, Suh BJ, Eccles MR. PAX3 Is extensively expressed in benign and malignant tissues of the melanocytic lineage in humans. J Invest Dermatol 2010, 130:1465-1468. 10.1038/jid.2009.434, 20107488.
20. Hou L, Panthier JJ, Arnheiter H. Signaling and transcriptional regulation in the neural crest-derived melanocyte lineage: interactions between KIT and MITF. Development 2000, 127:5379-5389.
21. Medic S, Rizos H, Ziman M. Differential PAX3 functions in normal skin melanocytes and melanoma cells. Biochem Biophys Res Commun 2011, 411:832-837. 10.1016/j.bbrc.2011.07.053, 21802410.
22. He X, Wang J, Messing EM, Wu G. Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness. Oncogene 2011, 30:535-547. 10.1038/onc.2010.427, 20871634.
23. Serrels B, Sandilands E, Serrels A, Baillie G, Houslay MD, Brunton VG, Canel M, Machesky LM, Anderson KI, Frame MC. A complex between FAK, RACK1, and PDE4D5 controls spreading initiation and cancer cell polarity. Curr Biol 2010, 20:1086-1092. 10.1016/j.cub.2010.04.042, 20493699.
24. Antony FC, Sanclemente G, Shaikh H, Trelles AS, Calonje E. Pigment synthesizing melanoma (so-called animal type melanoma): a clinicopathological study of 14 cases of a poorly known distinctive variant of melanoma. Histopathology 2006, 48:754-762. 10.1111/j.1365-2559.2006.02411.x, 16681693.
25. Barnhill RL, Gupta K. Unusual variants of malignant melanoma. Clin Dermatol 2009, 27:564-587. 10.1016/j.clindermatol.2008.09.015, 19880044.
26. Ludgate MW, Fullen DR, Lee J, Rees R, Sabel MS, Wong SL, Johnson TM. Animal-type melanoma: a clinical and histopathological study of 22 cases from a single institution. Br J Dermatol 2010, 162:129-136. 10.1111/j.1365-2133.2009.09271.x, 19709103.
27. Swetter SM, Ecker PM, Johnson DL, Harvell JD. Primary dermal melanoma: a distinct subtype of melanoma. Arch Dermatol 2004, 140:99-103. 10.1001/archderm.140.1.99, 14732666.
28. Roels S, Tilmant K, Van Daele A, Van Marck E, Ducatelle R. Proliferation, DNA ploidy, p53 overexpression and nuclear DNA fragmentation in six equine melanocytic tumours. J Vet Med A Physiol Pathol Clin Med 2000, 47:439-448. 10.1046/j.1439-0442.2000.00307.x, 11076465.
29. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009, 27:6199-6206. 10.1200/JCO.2009.23.4799, 2793035, 19917835.
30. Goldschmidt MH, Hendrick MJ. Tumors of the skin and soft tissues. Tumors in Domestic Animals 2002, 45-118. Iowa: Iowa State Press, Meuden DJ, 4.
31. Quatresooz P, Pierard-Franchimont C, Pierard GE. Molecular histology on the diagnostic cutting edge between malignant melanomas and cutaneous melanocytomas (Review). Oncol Rep 2009, 22:1263-1267.
32. Zembowicz A, Scolyer RA. Nevus/Melanocytoma/Melanoma: an emerging paradigm for classification of melanocytic neoplasms?. Arch Pathol Lab Med 2011, 135:300-306.
33. Jeglum KA. Melanomas. Current therapy in equine medecine 1997, 399-400. Philadelphia: Saunders W, Robinson NE, 3.